Navigation Links
The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit

Thomas Miller, CEO Workflow and Solutions Division, Siemens Healthcare, to

Serve as Event Keynote Speaker

PHILADELPHIA, Jan. 28 /PRNewswire-FirstCall/ -- Recent advances in genetic knowledge are transforming molecular imaging, molecular diagnostics and informatics to create stunningly precise diagnostic tools capable of assessing and treating a growing number of critical diseases. These new diagnostic tools provide physicians with an understanding of individual patient or disease differences at the molecular or genetic level, enabling them to leverage predictive diagnosis and tailor effective treatment to the individual.

(Logo: )

To address this new frontier in healthcare, Thomas Miller, CEO of Siemens Healthcare's Workflow and Solutions Division, will serve as a keynote speaker at the first international Molecular Summit on the integration of in vivo and in vitro diagnostics on February 5-6, 2008, at the Sheraton Society Hill Hotel in Philadelphia.

Miller will discuss Siemens' vision for a new era in medicine, one enabled through integration of molecular imaging, molecular diagnostics and informatics, specifically how the integration of these disciplines will lead to predictive diagnosis and individualized treatment - true personalized medicine, which will result in improved patient outcomes. Additionally, he will speak about Siemens' business strategy for becoming the world's first and pre-eminent leader in in vivo and in vitro diagnostics

About the Summit

The Dark Report and Siemens have assembled an international faculty of experts and early adopters of integrated diagnostic care pathways within radiology and pathology to address the first international Molecular Summit on the integration of in vivo and in vitro diagnostics.

Conference attendees will have a choice of attending more than 26 educational sessions to learn how innovators are advancing clinical care and enhancing their financial strength by incorporating the latest molecular imaging techniques in tandem with emerging molecular diagnostics. Industry pioneers will speak about evolving changes in R&D, the discovery of new medicines, effective policies to translate these discoveries into better outcomes for patients, resulting treatments that improve healthcare, and new business strategies to advance the field of personalized medicine. Continuing Education Units (CEU's) are provided by the American Association of Clinical Chemistry (AACC).

"Healthcare is evolving, entering a new era, one created through the marriage of in vivo and in vitro diagnostics, arming clinicians with the tools that enable early intervention and treatment in a way that improves clinical efficiencies, effectiveness and outcomes," said Thomas Miller, CEO, Workflow and Solutions Division, Siemens Healthcare. "We are ushering in the era of personalized medicine, moving the practice of medicine from the disease- centric to the knowledge-driven, patient-centric approach. For all of us who care passionately about this -- pathologists, radiologists and healthcare IT executives -- the Summit will deliver the latest information defining the next generation of integrated diagnostic and clinical services."

The Molecular Summit will feature case studies involving the delivery of molecular imaging and molecular diagnostics services, particularly where collaboration is occurring between radiology, pathology, and informatics to integrate molecular imaging with relevant molecular diagnostics services.

"Alert physicians involved in imaging and molecular diagnostics know these technology advances are already breaking down traditional specialty silos," said Robert L. Michel, editor, The Dark Report. "The Molecular Summit brings together early adopters who will share their practical experiences and discuss emerging opportunities."

Case studies and presentations will illustrate new technology, effective use of informatics to support molecular imaging and molecular diagnostics, and new developments in the way clinicians use these technologies. The Summit will also feature highlights of molecular diagnostics implemented in clinical laboratories, imaging centers, pathology groups, radiology groups, hospitals, and health systems. Speakers will deliver strategic presentations on how healthcare and diagnostic medicine will utilize molecular technologies in imaging, diagnostics and informatics in the future, and industry experts will conduct strategic assessments of the growing field of molecular medicine, identify emerging trends, and discuss how government and private payers are likely to respond with new coverage guidelines and reimbursement levels. More information about the event can be found at

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of euro 9.85, orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by visiting

SOURCE Siemens
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Varian, Inc. Reports First Quarter 2008 Results
2. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
3. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
4. VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
5. Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
6. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
7. Pharmasset Reports Fiscal Year End 2007 Financial Results
8. Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
10. Imagenetix Reports Results of Offer to Extend Warrants
11. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. ... will provide a corporate overview. th Annual Oppenheimer ... p.m. ET/10:00 a.m. PT . Jim Mazzola , vice ... overview. --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for ... of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference ... ISPE hosted the largest number of attendees in more than a decade. ...
Breaking Biology Technology:
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific discoveries ... doctors and other healthcare providers face challenges in better ... and patients. In addition, as more children continue to ... patient,s adulthood and old age. John M. ... Children,s Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
Breaking Biology News(10 mins):